Medical Condition News

RSS

Shifting towards precision medicine for type 2 diabetes dietary management

Researchers reviewed existing data on the genetic factors and the gene-diet interactions that could alter dietary management of type 2 diabetes.

8 Jun 2023

Pneumothorax prevalence in COVID-19 and influenza patients

Researchers examined the occurrence and patient risk factors involved in pneumothorax.

8 Jun 2023

The prevalence of inadequate iron intake among children in high-income countries

Researchers discussed iron nutrition among preschoolers residing in high-income countries.

8 Jun 2023

Assessing the role of Docetaxel post-chemoimmunotherapy for patients with NSCLC

A new research paper was published in Oncotarget's Volume 14 on May 26, 2023, entitled, "Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)."

8 Jun 2023

Study analyzes the prevalence of osteoporosis in postmenopausal women

Osteoporosis is a degenerative, debilitating bone disease that is increasingly prevalent in postmenopausal women.

8 Jun 2023

Level of fat within the body's muscle may lead to risk of cognitive decline while aging

New research reveals that the level of fat within the body's muscle - or muscle adiposity - may indicate a person's likelihood of experiencing cognitive decline as they age.

8 Jun 2023

Conventional speech therapy and singing may help improve patients' voice problems with Parkinson's

Speech and voice disorders are common in individuals with Parkinson's disease. New research published in the International Journal of Language & Communication Disorders found that a tele-rehabilitation program that combines conventional speech therapy and singing may help improve patients' voice problems.

7 Jun 2023

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

A clinical trial led by Yale Cancer Center shows that the drug osimertinib, a targeted therapy for non-small cell lung cancer, improved rates of survival and reduced risk of recurrence in patients after surgery.

7 Jun 2023

ATTR amyloidosis cardiomyopathy can be reversed, study reports

Three men who had heart failure caused by the build-up of sticky, toxic proteins are now free of symptoms after their condition spontaneously reversed in an unprecedented case described by a team at UCL (University College London) and the Royal Free Hospital.

7 Jun 2023

Scientists uncover key molecular culprit in ALS: PEG10 gene implicated in pathogenesis

UBQLN2 dysfunction in ALS leads to elevated PEG10 levels, suggesting a role for retrotransposon activity in the disease. PEG10's nuclear localization alters gene expression involved in axon remodeling, implicating it as a contributing mechanism in ALS.

7 Jun 2023

Heart attack during the first COVID-19 lockdown reduced two years of patients’ lives

Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to live 1.5 and 2 years less, respectively, than their pre-COVID counterparts.

7 Jun 2023

People with focal epilepsy often have seizures while driving before a diagnosis

Prior to being diagnosed with epilepsy, 5% of people with a type of epilepsy called focal epilepsy had a seizure while driving, according to a new study published in the June 7, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Jun 2023

People with insomnia symptoms may have higher stroke risk

People who have insomnia symptoms such as trouble falling asleep, staying asleep and waking up too early, may be more likely to have a stroke, according to a study published in the June 7, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

7 Jun 2023

New insights into the mechanisms underlying progression of Huntington's disease

New research led by a University of Ottawa Faculty of Medicine team is providing compelling insights into the mechanisms underlying the progression of Huntington's disease in an animal model.

7 Jun 2023

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic lymphocytic leukemia (CLL) whether or not their cancer harbored high-risk genetic features typically associated with poor outcomes, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).

7 Jun 2023

Medical Condition News

Shifting towards precision medicine for type 2 diabetes dietary management

Pneumothorax prevalence in COVID-19 and influenza patients

The prevalence of inadequate iron intake among children in high-income countries

Assessing the role of Docetaxel post-chemoimmunotherapy for patients with NSCLC

Study analyzes the prevalence of osteoporosis in postmenopausal women

Level of fat within the body's muscle may lead to risk of cognitive decline while aging

Conventional speech therapy and singing may help improve patients' voice problems with Parkinson's

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

ATTR amyloidosis cardiomyopathy can be reversed, study reports

Scientists uncover key molecular culprit in ALS: PEG10 gene implicated in pathogenesis

Heart attack during the first COVID-19 lockdown reduced two years of patients’ lives

People with focal epilepsy often have seizures while driving before a diagnosis

People with insomnia symptoms may have higher stroke risk

New insights into the mechanisms underlying progression of Huntington's disease

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

Study: One in three people with Type 2 diabetes in Austria suddenly stop treatment

Most adults with diabetes do not receive prompt outpatient care after heart failure hospitalization

UVA scientists discover a key determinant of multiple sclerosis risk

The HEART Clinic keeps rehab within the reach for stroke, Parkinson’s patients

Long Covid-related fatigue impacts daily lives of patients more than some cancers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News